Multiple sclerosis: open trials in United States

• NCT05051618

  Exercise Training for Managing Major Depressive Disorder in Multiple Sclerosis

  Trial Treatment · University of Illinois Chicago

  University of Illinois at Chicago, Chicago

  Registry updated 2026-06-04

• NCT03759522

  Assessment of Neuroinflammation in Central Inflammatory Disorders Using [F-18]DPA-714.

  Trial Treatment · Phase 1 · University of Alabama at Birmingham

  University of Alabama at Birmingham Medical Center, Birmingham

  Registry updated 2026-06-02

• NCT07614321

  Silodosin for Urinary Symptoms in Female Patients With Multiple Sclerosis

  Trial Treatment · Phase 4 · Atlantic Health System

  Atlantic Health, Morristown

  Registry updated 2026-05-29

• NCT07012135

  Deciphering Preserved Autonomic Function After Multiple Sclerosis

  Trial Treatment · Mayo Clinic

  Mayo Clinic, Rochester

  Registry updated 2026-05-28

• NCT06329453

  Intestinal Immunity in Neurologic Disease

  Research · Yale University

  Yale MS Clinic, North Haven

  Registry updated 2026-05-27

• NCT07221565

  Electromagnetic Immunotherapy Mapping and Cytokine Forecasting Study (QSIT)

  Trial Treatment · Phase 1/2 · Truway Health, Inc.

  Truway Health, Inc. www.truwayhealth.com (401 E 34th Street, S11P, New York, NY 10016), New York

  Registry updated 2026-05-22

• NCT00704626

  Serum Auto-Antibodies in Neurological Diseases

  Research · University of California, Davis

  University of California - Davis, Sacramento

  Registry updated 2026-05-18

• NCT01353547

  Genes and Environment in Multiple Sclerosis

  Research · Columbia University

  National Institute of Neurological Disorders and Stroke, Bethesda · Massachusetts General Hospital, Boston · Brigham and Women's Hospital, Boston · Columbia University Irving Center, New York · University of Pittsburgh, Pittsburgh

  Registry updated 2026-05-14

• NCT04603196

  Prevalence and Impact of Obstructive Sleep Apnea in Multiple Sclerosis

  Research · Beth Israel Deaconess Medical Center

  Beth Israel Deaconess Medical Center, Boston

  Registry updated 2026-05-11

• NCT05644522

  Nomad P-KAFO Study

  Trial Treatment · Shirley Ryan AbilityLab

  Shirley Ryan AbilityLab, Chicago

  Registry updated 2026-05-11

• NCT07167680

  Fall Prevention Among People With Spinal Cord Injury and Multiple Sclerosis Who Use Wheelchairs and Scooters

  Trial Treatment · University of Illinois at Urbana-Champaign

  Disability Participation and Quality of Life (DPQOL) Laboratory, Urbana

  Registry updated 2026-05-11

• NCT07389590

  Study of Ublituximab for Ocrelizumab Wearing-Off in Multiple Sclerosis

  Trial Treatment · Phase 4 · Johns Hopkins University

  Johns Hopkins University, Baltimore

  Registry updated 2026-05-06

• NCT03698149

  ECoG BMI for Motor and Speech Control

  Trial Treatment · Karunesh Ganguly

  University of California San Francisco, San Francisco

  Registry updated 2026-05-05

• NCT05183152

  Non-invasive BCI-controlled Assistive Devices

  Trial Treatment · University of Texas at Austin

  The University of Texas at Austin, Austin

  Registry updated 2026-05-01

• NCT04415372

  Macromolecular Imaging of White and Gray Matter Pathology in Multiple Sclerosis

  Research · University of Wisconsin, Madison

  University of Wisconsin - Madison, Madison

  Registry updated 2026-04-28

• NCT06591429

  Smoldering Inflammation in MS

  Research · Washington University School of Medicine

  Barnes Jewish Center for Clinical Imaging Research, St Louis

  Registry updated 2026-04-28

• NCT06860932

  A Palliative Care Model Impact on Knowledge and Attitudes

  Trial Treatment · Hunter College of City University of New York

  Hunter College, New York · Judith Jaffe Multiple Sclerosis Center, New York

  Registry updated 2026-04-22

• NCT02553525

  Effects of Stimulation Patterns of Deep Brain Stimulation

  Trial Treatment · Duke University

  Emory University, Atlanta · Duke University, Durham · University of Florida, Gainesville

  Registry updated 2026-04-09

• NCT07500727

  Skeletal Muscle Aging and Responsiveness in Aged People With MS

  Trial Treatment · Oklahoma Medical Research Foundation

  Oklahoma Medical Research Foundation, Oklahoma City

  Registry updated 2026-03-30

• NCT06495593

  Effects of Ocrelizumab Treatment on Immune Cells in Lymph Nodes in Multiple Sclerosis

  Trial Treatment · Phase 4 · University of California, San Francisco

  University of California San Francisco, San Francisco

  Registry updated 2026-03-27

• NCT07492602

  Comparison of Gait Metrics in Patients With Stroke, Traumatic Brain Injury, and Multiple Sclerosis

  Trial Treatment · Casa Colina Hospital and Centers for Healthcare

  Casa Colina Hospital and Centers for Healthcare, Pomona

  Registry updated 2026-03-27

• NCT06072703

  Neuromodulating Cortical Regions Involved in Neurogenic Bladder in MS

  Trial Treatment · The Methodist Hospital Research Institute

  Houston Methodist Hospital, Houston

  Registry updated 2026-03-23

• NCT06276634

  Intermittent Hypoxia in Persons With Multiple Sclerosis

  Trial Treatment · Shirley Ryan AbilityLab

  Shirley Ryan AbilityLab, Chicago

  Registry updated 2026-03-20

• NCT07207148

  People With Multiple Sclerosis Treated With Ocrelizumab and GLP-1 Agonists

  Research · Northwestern University

  Northwestern Memorial Hospital, Chicago

  Registry updated 2026-03-17

• NCT07225361

  Ublituximab (Briumvi) for Early Forms of Relapsing Multiple Sclerosis

  Trial Treatment · Phase 4 · Northwestern University

  Northwestern Memorial Hospital, Chicago

  Registry updated 2026-03-17

All Multiple sclerosis trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error